Market Cap (In BRL)
1.29 Billion
Revenue (In BRL)
118.19 Million
Net Income (In BRL)
-81.14 Million
Avg. Volume
57.31 Thousand
- Currency
- BRL
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.0-21.2
- PE
- -16.21
- EPS
- -0.63
- Beta Value
- 0.906
- ISIN
- BRBIOMACNOR2
- CUSIP
- -
- CIK
- -
- Shares
- 126842000.0
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Heraldo Carvalho Marchezini
- Employee Count
- -
- Website
- https://www.biomm.com
- Ipo Date
- 2000-01-11
- Details
- Biomm S.A. operates as a biotechnology company in Brazil. It offers AFREZZA, a human insulin inhalation powder; CONFORT CARE, a moisturizing foot cream; GLARGILIN, a glargine insulin; and HERZUMA, a trastuzumab. Biomm S.A. was founded in 2001 and is based in São Paulo, Brazil.
More Stocks
-
BMDPF
-
KLIB
-
TTDKFTDK Corporation
TTDKF
-
600660
-
7757
-
SOFTSoftimat S.A.
SOFT
-
BOZTYBoozt AB (publ)
BOZTY
-
EEVIAEevia Health Plc
EEVIA